The packaging image may vary depending on the country in which it is marketed.

Logotipo CZ Vaccines
Manufacturer
CZ Vaccines, S.A.U
Medicinal product subject to veterinary prescription

NEOLEISH

Vaccine against Leishmania infantum for dogs, in a nasal spray solution
Target species
Dogs icon
Dogs
Composition
Each 1 ml dose contains:

Supercoiled plasmid DNA pPAL-LACK encoding the LACK protein of
Leishmania infantum 212,5-250 μg
Indications
For the active immunisation of dogs negative for Leishmania from 6 months of age, to reduce the risk of developing an active infection and/or clinical disease after contact with Leishmania infantum.
Route of administration
Nasal.
Dosage
Dose: 2ml
Vaccination schedule:
  • Primary vaccination
    • 1 dose: 6 months the first.
    • 1 dose: 2 weeks after of age.

  • Revaccination
    • 1 dose. 6 months after primary vaccination
Withdrawal period
Not required.

La imagen puede variar dependiendo del país en el que se comercialice.

Laboratorio fabricante
CZ Vaccines S.A.U.
Medicamento sujeto a prescripción veterinaria

NEOLEISH

Vaccine against Leishmania infantum for dogs, in a nasal spray solution
Composición
Each 1 ml dose contains:

Supercoiled plasmid DNA pPAL-LACK encoding the LACK protein of
Leishmania infantum 212,5-250 μg
Indicaciones
For the active immunisation of dogs negative for Leishmania from 6 months of age, to reduce the risk of developing an active infection and/or clinical disease after contact with Leishmania infantum.
Vía de administración
Nasal.
Posología
Dose: 2ml
Pauta de vacunación
  • Primary vaccination
    • 1 dose: 6 months the first.
    • 1 dose: 2 weeks after of age.

  • Revaccination
    • 1 dose. 6 months after primary vaccination
Tiempo de espera
Not required.
Scroll to Top